Vivos Therapeutics, Inc.

About Vivos Therapeutics, Inc.

Vivos is a company focused on providing non-surgical solutions for Obstructive Sleep Apnea (OSA). Their mission is to offer innovative, non-invasive treatments through The Vivos Method, which reshapes and expands the oral cavity to improve breathing and sleep, targeting the root causes of OSA such as underdeveloped jaws and oral cavities. They aim to transform lives with multidisciplinary healthcare approaches, helping over 40,000 patients worldwide.

Products & Services

Vivos CARE Oral Medical Devices:Oral devices cleared by the FDA to treat mild, moderate, and severe OSA in adults, used alongside positive airway pressure (PAP) and/or myofunctional therapy as needed.

The Vivos Method:A revolutionary, non-invasive treatment using cost-effective oral appliance technology prescribed by trained dentists and medical professionals to address dentofacial abnormalities and OSA, with an average treatment time of about 12 months.

AireO2:A product or service related to Vivos' offerings for OSA treatment, though specific details are not provided in the content.

Billing Intelligence Service:A service to support providers with medical billing processes related to Vivos treatments.

Specialties

Obstructive Sleep Apnea (OSA) treatment Non-surgical oral appliance technology Dentofacial abnormality correction Multidisciplinary healthcare solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Warrant Exercise T: - FT: Warrant Exercise	A: 4640000 MR: - FA: 4.64 million FAN: 4640000	D: 2026-01-20 FD: 2026-01-20	1 investors
2	RT: Warrant Exercise T: - FT: Warrant Exercise	A: 4640000 MR: - FA: approximately $4.64 million FAN: 4640000	D: 2026-01-16 FD: 2026-01-16	1 investors
3	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 3500000 MR: - FA: $3.5 million FAN: 3500000	D: 2024-12-23 FD: 2024-12-23	-
4	RT: Private Placement T: - FT: Private Placement	A: 7500000 MR: - FA: $7.5 million FAN: 7500000	D: 2024-06-12 FD: 2024-06-12	1 investors
5	RT: Warrant Exercise T: - FT: Warrant Exercise	A: 4000000 MR: - FA: approximately $4.0 million FAN: 4000000	D: 2024-02-15 FD: 2024-02-15	1 investors

Warrant Exercise Latest

2026-01-20

$4.6M

1 investor (Pro only)

Warrant Exercise 2026-01-16

$4.6M

Registered Direct Offering 2024-12-23

$3.5M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Paul Lawrence

Dentist

D

Dr. Paul Lawrence

Dentist

D

Dr. Buske

Dentist

N

Nathanson

Doctor

J

Joel Nathanson

Dentist and Vivos Integrated Provider

G

Garcia DePalma

Doctor

View 35 more team members with Pro

Unlock Full Team Directory

Recent News